Global Ai-based Clinical Trials Solution Provider Market Size & Outlook
Global ai-based clinical trials solution provider market, 2018-2030 (US$M)
Related Markets
Global ai-based clinical trials solution provider market highlights
- The global ai-based clinical trials solution provider market generated a revenue of USD 1,319.9 million in 2021 and is expected to reach USD 7,833.5 million by 2030.
- The market is expected to grow at a CAGR (2022 - 2030) of 21.9% by 2030.
- In terms of segment, oncology accounted for a revenue of USD 307.7 million in 2021.
- CVD is the most lucrative therapeutic applications segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2021.
- Country-wise, U.S. is expected to register the highest CAGR from 2022 to 2030.
Global data book summary
| Market revenue in 2021 | USD 1,319.9 million |
| Market revenue in 2030 | USD 7,833.5 million |
| Growth rate | 21.9% (CAGR from 2021 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | CVD |
| Historical data covered | 2018 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
Other key industry trends
- In terms of revenue, the North America accounted for 43.8% of the global ai-based clinical trials solution provider market in 2021.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, U.S. is the fastest growing regional market and is projected to reach USD 2,165.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
AI-based Clinical Trials Solution Provider Market Scope
AI-based Clinical Trials Solution Provider Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Median Technologies | View profile | 101-250 | Valbonne, Provence-Alpes-Cote d'Azur, France, Europe | http://www.mediantechnologies.com |
| SAI.TECH Global Corp | View profile | 37 | 195 Pearl’s Hill Terrace, Number 01-05, Singapore, Singapore, 168976 | https://www.sai.tech |
| Exscientia PLC ADR | View profile | 483 | Oxford Science Park, The Schrodinger Building, Oxford, United Kingdom, OX4 4GE | https://www.exscientia.ai |
| The Carlyle Group Inc | View profile | 2200 | 1001 Pennsylvania Avenue, NW, Washington, DC, United States, 20004-2505 | https://www.carlyle.com |
| Mendel.ai | View profile | 101-250 | San Jose, California, United States, North America | https://mendel.ai/ |
| Alphabet Inc Class A | View profile | 180895 | 1600 Amphitheatre Parkway, Mountain View, CA, United States, 94043 | https://www.abc.xyz |
Global ai-based clinical trials solution provider market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.31% in 2021. Horizon Databook has segmented the Global ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
- Global AI-based Clinical Trials Solution Provider Therapeutic Applications Outlook (Revenue, USD Million, 2018-2030)
- Oncology
- CVD
- Neurological Diseases or conditions
- Metabolic diseases
- Infectious diseases
- Others
- Global AI-based Clinical Trials Solution Provider Clinical Trial Phase Outlook (Revenue, USD Million, 2018-2030)
- Phase-I
- Phase-II
- Phase-III
- Global AI-based Clinical Trials Solution Provider End User Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical Companies
- Academia
- Others
Reasons to subscribe to Global ai-based clinical trials solution provider market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global ai-based clinical trials solution provider market databook
-
Our clientele includes a mix of ai-based clinical trials solution provider market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global ai-based clinical trials solution provider market, including forecasts for subscribers. This global databook contains high-level insights into Global ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global artificial intelligence based clinical trials solution provider market size, by regions, 2018-2030 (US$M)
Top 10 countries: Artificial intelligence based clinical trials solution provider market size, 2021 (US$M)
Global artificial intelligence based clinical trials solution provider market share, by therapeutic applications, 2021 & 2030 (%, US$M)
Ai-based clinical trials solution provider market: Opportunity assessment by country
Global ai-based clinical trials solution provider market, by region, 2021 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
